Načítá se...
Fulvestrant for hormone‐sensitive metastatic breast cancer
BACKGROUND: Fulvestrant is a selective oestrogen receptor down‐regulator (SERD), which by blocking proliferation of breast cancer cells, is an effective endocrine treatment for women with hormone‐sensitive advanced breast cancer. The goal of such systemic therapy in this setting is to reduce symptom...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2017
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464820/ https://ncbi.nlm.nih.gov/pubmed/28043088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011093.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|